Global Sleeping Bruxism Treatment Market Growth (Status and Outlook) 2023-2029

Global Sleeping Bruxism Treatment Market Growth (Status and Outlook) 2023-2029

Bruxism is excessive teeth grinding or jaw clenching. It is an oral parafunctional activity; i.e., it is unrelated to normal function such as eating or talking. Bruxism is a common behavior; reports of prevalence range from 8–31% in the general population. Several symptoms are commonly associated with bruxism, including hypersensitive teeth, aching jaw muscles, headaches, tooth wear, and damage to dental restorations (e.g. crowns and fillings) to teeth. But symptoms may be minimal, without patient awareness of the condition.

LPI (LP Information)' newest research report, the “Sleeping Bruxism Treatment Industry Forecast” looks at past sales and reviews total world Sleeping Bruxism Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Sleeping Bruxism Treatment sales for 2023 through 2029. With Sleeping Bruxism Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sleeping Bruxism Treatment industry.

This Insight Report provides a comprehensive analysis of the global Sleeping Bruxism Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sleeping Bruxism Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sleeping Bruxism Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sleeping Bruxism Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sleeping Bruxism Treatment.

The global Sleeping Bruxism Treatment market size is projected to grow from US$ 450.7 million in 2022 to US$ 590.8 million in 2029; it is expected to grow at a CAGR of 3.9% from 2023 to 2029.

Increasing prevalence of sleeping bruxism, rise in pediatric population, and changing lifestyles are factors expected to drive market growth over the forecast period. Availability of therapeutic medicines in the form of antidepressants, muscle relaxants, and others can provide growth opportunities to the market. But high costs of custom-made night guards and lack of treatment options for SB can impede the market.

This report presents a comprehensive overview, market shares, and growth opportunities of Sleeping Bruxism Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Treatment
Diagnosis

Segmentation by application
Hospitals
Dental Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Carestream Dental (US)
Pfizer Inc. (US)
Ipsen Biopharmaceuticals(US)
Henry Schein(US)
PLANMECA OY (Finland)
Patterson Dental Supply(US)
Randmark Dental Products, LLC (US)
Akervall Technologies Inc. (US)
Merz Pharma GmbH & Co. KGaA (Germany)
S4S Dental Laboratory (U.K.)
Ivoclar Vivadent AG (Liechtenstein)

Please note: The report will take approximately 2 business days to prepare and deliver.